Pharmacovigilance
Pharmacovigilance
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| MabThera® - Rituximab | 2013-07-16 | The management of hepatitis B reactivation in patients treated with MabThera®. CLICK HERE |
|
| MabThera® - Rituximab | 2013-04-01 | Risk of Toxic Epidermal Necrolysis And Stevens-Johnson-Syndrome |
|